Organovo Holdings, Inc. (ONVO)

[thewind]

Simple questions I didn't hear on the conference call...

Where was the proactive anticipation of customers request to test in different forms for validation?

Big pharma is paying millions to get the drugs to this point. They are going to want enough proof to scrap a drug or continue.

It's understood the revenue stream keeps the company afloat until therapeutic tissue Is developed.
Large pharma is aware you are a small fragile company. They also know that they can get your technology for pennies on the dollar if WE go belly up. Then squash it and keep selling pills and devices until they can phase out and in at a profit.

So the question becomes...are these add on services going to bepart of the larger package and now charged for?

Letting them bleed out cash flow so that forward progress becomes impossible is a real threat. The science will destroy large parts of the pharma industry.

Is the veterinary market a viable proving ground for therapeutic tissue, what is the FDA process and is it easier get approved and noticeable exposer?

This is an open air question I need to research more myself.

But overall disappointed in the lack of forward thinking in regards to posturing of big pharma to crush revenues by being a "tough customer" ....of course they don't like you. If you can save them money while they cost you money, all the better for them.